Dividend Overview
Dividend Yield
3.58%
Dividend / Share
$2.80
Medtronic Plc
Exchange: NYSESector: HealthcareIndustry: Medical Devices
As the global market leader, Medtronic Cranial and Spinal Technologies is transforming the standard of care in spine and cranial surgery by putting patients first and addressing the complex challenges faced by spine and neurosurgeons. With a portfolio of 150 products covering more than 20 pathologies, we serve over 4 million patients annually. Building on a legacy of innovation, our AiBLE™ ecosystem integrates advanced technologies, data, and AI with a patient-centric approach, offering customizable solutions to enhance surgical precision, improve workflow efficiency, and achieve better outcomes, before, during, and beyond surgery. About Medtronic Bold thinking. Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.
Did you know?
Free cash flow has been growing at -2.1% annually.
Current Price
$78.30
-2.13%GoodMoat Value
$53.32
31.9% overvaluedProfile
Valuation (TTM)
Market Cap$100.38B
P/E21.76
EV$131.44B
P/B2.09
Shares Out1.28B
P/Sales2.83
Revenue$35.48B
EV/EBITDA12.87
Medtronic Plc (MDT) Dividends
GoodMoat Analysis
Medtronic's dividend appears sustainable with a moderate payout ratio and strong free cash flow coverage, but its yield is slightly below the sector average. The dividend has a history of growth, supported by a solid balance sheet. For an income-focused value investor, the profile is adequate but not exceptional.
Read full analysis
Medtronic's dividend sustainability is supported by a moderate payout ratio and robust free cash flow. The current dividend yield of 3.19% is slightly below the broader Healthcare sector average of approximately 3.5%, making it less attractive for pure yield-seeking investors. However, the company has a long track record of growing its dividend, which is a positive signal for income growth. The payout is well-covered by free cash flow, with an FCF yield of 4.6% indicating the company generates sufficient cash after capital expenditures to support the distribution. Referencing the GoodMoat Investment Framework's Quality Indicators, the balance sheet is a strength with a Debt/Equity ratio of 0.59, which is conservative and well below the framework's caution threshold of 1.0x Debt/EBITDA. This low leverage provides a cushion for maintaining the dividend during economic downturns. The 8.7% YoY revenue growth also suggests underlying business momentum that can support future dividend increases. The primary consideration for a value investor is that while the dividend is safe and growing, the current yield is not compelling relative to the sector, and the stock's valuation, as indicated by the GoodMoat Target, suggests the price may be elevated, which could limit near-term total return potential for an income-focused portfolio. Analysis based on data as of 2024-05-15.
Key Metrics
Market Cap
$100.38B
P/E Ratio
21.76
Forward P/E
—
EPS
$3.61
PEG Ratio
-1.83
Book Value
$37.46
Dividend Yield
3.58%
Profit Margin
13.00%
ROE
9.61%
Dividend History
Dividend Safety
MDT Dividend Analysis
Medtronic Plc (MDT) dividend analysis including yield, payout history, and sustainability metrics. The current dividend yield is 3.58%. The annual dividend per share is $2.80.
P/E ratio: 21.76. Profit margin: 13.00%. Free cash flow: $5.18B. This page shows Medtronic Plc's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.
GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Medtronic Plc's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.